Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 4

Icariin Inhibits Intestinal Inflammation of DSS-Induced Colitis Mice Through Modulating Intestinal Flora Abundance and Modulating p-p65/p65 Molecule

Pages
382–392
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: ICA can improve intestinal flora abundance and composition of DSS-induced colitis mice, and inhibit tissue damage and inflammatory response through modulating the p-p65/p65 expression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Ulcerative colitis, as a kind of inflammatory bowel disease (IBD) is characterized by abdominal pain.
📊
Key Findings & Data:Methods: Fifteen female C57BL/6 mice were randomly divided into the Control group, dextran sodium sulfate (DSS)-induced colitis (DSS) group, and ICA treatment (DSS+ICA) group.
💡
Conclusion & Impact:Conclusion: ICA can improve intestinal flora abundance and composition of DSS-induced colitis mice, and inhibit tissue damage and inflammatory response through modulating the p-p65/p65 expression.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: Ulcerative colitis, as a kind of inflammatory bowel disease (IBD) is characterized by abdominal pain. This study aimed to investigate the effect of icariin (ICA) on the intestinal microflora of colitis mice. Methods: Fifteen female C57BL/6 mice were randomly divided into the Control group, dextran sodium sulfate (DSS)-induced colitis (DSS) group, and ICA treatment (DSS+ICA) group. The severity of inflammation in DSS-induced colitis mice was evaluated using disease activity scoring (considering weight-loss percentage, stool-shape change, and stool-bleeding scoring). Pathological changes of mice intestinal tract were evaluated using hematoxylin–eosin (HE) staining. Serum levels of TNF-α and IL-6 were detected with enzyme-linked immunosorbent assay. Expressions of p65 and p-p65 (p-p65/p65 ratio) were analyzed using Western blot assay. 16S rDNA sequencing was used to analyze the abundance and composition of intestinal microflora. Results: Compared with DSS group, ICA significantly improved disease activity (P < .05) and reduced inflammatory damage of colon tissues (P < .05) in DSS-induced colitis mice. Compared with the DSS group, mice in the ICA group demonstrated significant weight and colon length (P < .05). ICA significantly inhibited expressions of IL-6 and TNF-α compared to the DSS group (P < .05). p-p65/ p65 ratio in the DSS + ICA group was remarkably enhanced compared to the DSS group (P < .05). ICA significantly reduced the proportion and activity of Bacteroides, Helicobacteraceae, Turicibacter, and significantly increased that of beneficial microflora (Lactobacillus, Lachnospiraceae, Akkermansia), so as improved damages of colon tissues. Conclusion: ICA can improve intestinal flora abundance and composition of DSS-induced colitis mice, and inhibit tissue damage and inflammatory response through modulating the p-p65/p65 expression.

🔖

Cite This Article

HAORAN, Z., SHİXUAN, Z., GU, Y., CHEN, M., YUANYUAN, G., SONG, D., WANG, L., GU, J., Jİ, M., MA, J. (2021). Icariin Inhibits Intestinal Inflammation of DSS-Induced Colitis Mice Through Modulating Intestinal Flora Abundance and Modulating p-p65/p65 Molecule. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 4, 382–392. https://ajindex.com/articles/408879

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yılmaz İ, Dolar ME, Özpınar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A ransomized controlled trial. Turk J Gastroenterol. 2019;30(3):242-253. [CrossRef]
  2. Núñez FP, Quera PR, Gomollón F. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation. Gastroenterol Hepatol. 2019;42(5):316-325. [CrossRef]
  3. Yu YR, Rodriguez JR. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26(6):349-355. [CrossRef]
  4. Coope A, Pascoal LB, da Silva FAR, et al. Transcriptional and molecular pathways activated in mesenteric adipose tissue and intestinal mucosa of Crohn’s disease patients. Int J Inflam. 2017;2017:7646859. [CrossRef]
  5. Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives. World J Gastroenterol. 2014;20(33):11525-11537. [CrossRef]
  6. Klaassen MAY, Imhann F, Collij V, et al. Anti-inflammatory gut microbial pathways are decreased during Crohn’s disease exacerbations. J Crohns Colitis. 2019;13(11):1439-1449. [CrossRef]
  7. Figliuolo VR, Coutinho-Silva R, Coutinho CMLM. Contribution of sulfate-reducing bacteria to homeostasis disruption during intestinal inflammation. Life Sci. 2018;215:145-151. [CrossRef]
  8. Parian A, Limketkai BN. Dietary supplement therapies for inflammatory bowel disease: Crohn’s disease and ulcerative colitis. Curr Pharm Des. 2016;22(2):180-188. [CrossRef]
  9. Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention and treatment methods of inflammatory bowel disease. J Med Life. 2019;12(2):113-122. [CrossRef]
  10. Nelson SM, Nguyen TM, McDonald JW, MacDonald JK. Natalizumab for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2018;8(8):CD006097. [CrossRef]
  11. Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Systemic review with meta-analysis: Comparative efficacy of immunosuppreants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;45(1):3-13. [CrossRef]
  12. Tripathi K, Feuerstein JD. New developments in ulcerative colitis: Latest evidence on management, treatment, and maintenance. Drugs Context. 2019;8:212572. [CrossRef]
  13. Sang TT, Guo CJ, Guo DD, Wang XY. Effect of traditio